Vivid Genomics

Vivid Genomics is a company developing non-invasive genomic tools to identify underlying neurodegenerative disease pathologies, drug response, and progression rate. It offers AmyloidGB, a test that predicts the presence of amyloid plaques, ProgressionGB, a solution providing information on predicted Alzheimer’s disease progression rate, and more.